Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000799048 | SCV000938695 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 | 2018-11-08 | criteria provided, single submitter | clinical testing | This sequence change affects codon 171 of the B4GAT1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the B4GAT1 protein. This variant is present in population databases (rs750370418, ExAC 0.002%). This variant has not been reported in the literature in individuals with B4GAT1-related disease. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |